SECOND AMENDMENT TO INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • July 19th, 2018 • Oncobiologics, Inc. • Biological products, (no disgnostic substances)
This SECOND AMENDMENT, dated as of July 18, 2018 (this “Second Amendment”), to the Investor Rights Agreement, dated as of September 11, 2017 (as it may be amended from time to time, the “Investor Rights Agreement”), is entered into between Oncobiologics, Inc., a Delaware corporation (the “Company”), and GMS Tenshi Holdings Pte. Limited, a Singapore private limited company (the “Investor” and, collectively with the Company, the “Parties”). Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Investor Rights Agreement.
EXCHANGE AGREEMENT by and between ONCOBIOLOGICS, Inc. and GMS TENSHI HOLDINGS PTE. LIMITED Dated July 18, 2018Exchange Agreement • July 19th, 2018 • Oncobiologics, Inc. • Biological products, (no disgnostic substances) • New York
This EXCHANGE AGREEMENT (this “Agreement”), dated as of July 18, 2018, is entered into by and between Oncobiologics, Inc., a Delaware corporation (the “Company”), and GMS Tenshi Holdings Pte. Limited, a Singapore private limited company (“Investor”).
